AAAAAA

   
Results: 1-25 | 26-41
Results: 1-25/41
DRUG-INTERACTIONS WITH ANTIPSYCHOTIC AGENTS - INCIDENCE AND THERAPEUTIC IMPLICATIONS
Authors: ZUMBRUNNEN TL JANN MW
Citation: Tl. Zumbrunnen et Mw. Jann, DRUG-INTERACTIONS WITH ANTIPSYCHOTIC AGENTS - INCIDENCE AND THERAPEUTIC IMPLICATIONS, CNS DRUGS, 9(5), 1998, pp. 381-401
PHARMACOLOGY AND CLINICAL EFFICACY OF CHOLINESTERASE-INHIBITORS
Authors: JANN MW
Citation: Mw. Jann, PHARMACOLOGY AND CLINICAL EFFICACY OF CHOLINESTERASE-INHIBITORS, American journal of health-system pharmacy, 55, 1998, pp. 22-25
PSYCHIATRIC PHARMACY PRACTICE SPECIALTY CERTIFICATION PROCESS
Authors: CRISMON ML FANKHAUSER MP HINKLE GH JANN MW JUNI H LOVE RC RAY MD STIMMEL GL WELLS BG
Citation: Ml. Crismon et al., PSYCHIATRIC PHARMACY PRACTICE SPECIALTY CERTIFICATION PROCESS, American journal of health-system pharmacy, 55(15), 1998, pp. 1594-1598
REVERSIBLE METABOLISM OF CLOZAPINE AND CLOZAPINE N-OXIDE IN SCHIZOPHRENIC-PATIENTS
Authors: CHANG WH LIN SK LANE HY WEI FC HU WH LAM YWF JANN MW
Citation: Wh. Chang et al., REVERSIBLE METABOLISM OF CLOZAPINE AND CLOZAPINE N-OXIDE IN SCHIZOPHRENIC-PATIENTS, Progress in neuro-psychopharmacology & biological psychiatry, 22(5), 1998, pp. 723-739
PRECLINICAL PHARMACOLOGY OF METRIFONATE
Authors: JANN MW
Citation: Mw. Jann, PRECLINICAL PHARMACOLOGY OF METRIFONATE, Pharmacotherapy, 18(2), 1998, pp. 55-67
RELATIVE BIOAVAILABILITY OF ONDANSETRON 8-MG ORAL TABLETS VERSUS 2 EXTEMPORANEOUS 16-MG SUPPOSITORIES - FORMULATION AND GENDER DIFFERENCES
Authors: JANN MW ZUMBRUNNEN TL TENJARLA SN WARD ES WEIDLER DJ
Citation: Mw. Jann et al., RELATIVE BIOAVAILABILITY OF ONDANSETRON 8-MG ORAL TABLETS VERSUS 2 EXTEMPORANEOUS 16-MG SUPPOSITORIES - FORMULATION AND GENDER DIFFERENCES, Pharmacotherapy, 18(2), 1998, pp. 288-294
INCREASED LITHIUM SERUM AND RED-BLOOD-CELL CONCENTRATIONS DURING KETOROLAC COADMINISTRATION
Authors: COLD JA ZUMBRUNNEN TL SIMPSON MA AUGUSTIN BG AWAD E JANN MW
Citation: Ja. Cold et al., INCREASED LITHIUM SERUM AND RED-BLOOD-CELL CONCENTRATIONS DURING KETOROLAC COADMINISTRATION, Journal of clinical psychopharmacology, 18(1), 1998, pp. 33-37
ELEVATED PLASMA CLOZAPINE CONCENTRATIONS AFTER PHENOBARBITAL DISCONTINUATION
Authors: LANE HY SU KP CHANG WH JANN MW
Citation: Hy. Lane et al., ELEVATED PLASMA CLOZAPINE CONCENTRATIONS AFTER PHENOBARBITAL DISCONTINUATION, The Journal of clinical psychiatry, 59(3), 1998, pp. 131-133
EFFECTS OF FLUVOXAMINE ON CLOZAPINE KINETICS IN SCHIZOPHRENIC-PATIENTS
Authors: CHANG WH LANE HY LIU HC CHEN CH CHIU CC JANN MW
Citation: Wh. Chang et al., EFFECTS OF FLUVOXAMINE ON CLOZAPINE KINETICS IN SCHIZOPHRENIC-PATIENTS, Biological psychiatry, 43, 1998, pp. 364-364
EFFECTS OF GENDER AND AGE ON PLASMA CLOZAPINE AND METABOLITES LEVELS
Authors: LANE HY CHANG WH LIN SK JANN MW
Citation: Hy. Lane et al., EFFECTS OF GENDER AND AGE ON PLASMA CLOZAPINE AND METABOLITES LEVELS, Biological psychiatry, 43, 1998, pp. 365-365
CLOZAPINE DOSAGES AND PLASMA DRUG CONCENTRATIONS
Authors: CHANG WH LIN SK LANE HY HU WH JANN MW LIN HN
Citation: Wh. Chang et al., CLOZAPINE DOSAGES AND PLASMA DRUG CONCENTRATIONS, Journal of the Formosan Medical Association, 96(8), 1997, pp. 599-605
GENDER DIFFERENCES IN PLASMA CLOZAPINE LEVELS AND ITS METABOLITES IN SCHIZOPHRENIC-PATIENTS
Authors: JANN MW LIU HC WEI FC LIN SK LIN SK HU WH CHANG WH
Citation: Mw. Jann et al., GENDER DIFFERENCES IN PLASMA CLOZAPINE LEVELS AND ITS METABOLITES IN SCHIZOPHRENIC-PATIENTS, Human psychopharmacology, 12(5), 1997, pp. 489-495
PLASMA ALPHA-ONE ACID GLYCOPROTEIN AND HALOPERIDOL CONCENTRATIONS IN SCHIZOPHRENIC-PATIENTS
Authors: JANN MW CRABTREE BL PITTS WM LAM YWF CARTER JG
Citation: Mw. Jann et al., PLASMA ALPHA-ONE ACID GLYCOPROTEIN AND HALOPERIDOL CONCENTRATIONS IN SCHIZOPHRENIC-PATIENTS, Neuropsychobiology, 36(1), 1997, pp. 32-36
BLOOD-LEVELS OF REDUCED HALOPERIDOL VERSUS CLINICAL EFFICACY AND EXTRAPYRAMIDAL SIDE-EFFECTS OF HALOPERIDOL
Authors: LANE HY LIN HN HU OYP CHEN CC JANN MW CHANG WH
Citation: Hy. Lane et al., BLOOD-LEVELS OF REDUCED HALOPERIDOL VERSUS CLINICAL EFFICACY AND EXTRAPYRAMIDAL SIDE-EFFECTS OF HALOPERIDOL, Progress in neuro-psychopharmacology & biological psychiatry, 21(2), 1997, pp. 299-311
VENLAFAXINE AND NEFAZODONE, 2 PHARMACOLOGICALLY DISTINCT ANTIDEPRESSANTS
Authors: AUGUSTIN BG COLD JA JANN MW
Citation: Bg. Augustin et al., VENLAFAXINE AND NEFAZODONE, 2 PHARMACOLOGICALLY DISTINCT ANTIDEPRESSANTS, Pharmacotherapy, 17(3), 1997, pp. 511-530
DOSE-DEPENDENT REDUCED HALOPERIDOL HALOPERIDOL RATIOS - INFLUENCE OF PATIENT-RELATED VARIABLES
Authors: LANE HY CHANG WH CHANG YC HU OYP LIN HN JANN MW HU WH
Citation: Hy. Lane et al., DOSE-DEPENDENT REDUCED HALOPERIDOL HALOPERIDOL RATIOS - INFLUENCE OF PATIENT-RELATED VARIABLES, Psychiatry research, 72(2), 1997, pp. 127-132
DEXTROMETHORPHAN PHENOTYPING AND HALOPERIDOL DISPOSITION IN SCHIZOPHRENIC-PATIENTS
Authors: LANE HY HU OYP JANN MW DENG HC LIN HN CHANG WH
Citation: Hy. Lane et al., DEXTROMETHORPHAN PHENOTYPING AND HALOPERIDOL DISPOSITION IN SCHIZOPHRENIC-PATIENTS, Psychiatry research, 69(2-3), 1997, pp. 105-111
IN-VITRO METABOLISM OF CLOZAPINE IN HUMAN HEPATIC MICROSOMES
Authors: AUGUSTIN BG THURSTON A THOMAS G HUI J JANN MW
Citation: Bg. Augustin et al., IN-VITRO METABOLISM OF CLOZAPINE IN HUMAN HEPATIC MICROSOMES, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 55-55
GENDER DIFFERENCES IN PLASMA CLOZAPINE CONCENTRATIONS
Authors: CHANG WH JANN MW LIU HC WEI FC LIN SK HU WH
Citation: Wh. Chang et al., GENDER DIFFERENCES IN PLASMA CLOZAPINE CONCENTRATIONS, Biological psychiatry, 41, 1997, pp. 169-169
DISPOSITION OF REMOXIPRIDE IN CHINESE SCHIZOPHRENIC-PATIENTS
Authors: LIN SK CHANG WH CHIEN CP LAM YWF JANN MW
Citation: Sk. Lin et al., DISPOSITION OF REMOXIPRIDE IN CHINESE SCHIZOPHRENIC-PATIENTS, International journal of clinical pharmacology and therapeutics, 34(1), 1996, pp. 17-20
PLASMA HALOPERIDOL AND REDUCED HALOPERIDOL CONCENTRATIONS IN A GERIATRIC POPULATION
Authors: CHANG WH JANN MW CHIANG TS LIN HN HU WH CHIEN CP
Citation: Wh. Chang et al., PLASMA HALOPERIDOL AND REDUCED HALOPERIDOL CONCENTRATIONS IN A GERIATRIC POPULATION, Neuropsychobiology, 33(1), 1996, pp. 12-16
HALOPERIDOL AND REDUCED HALOPERIDOL PLASMA-CONCENTRATIONS AFTER A LOADING DOSE REGIMEN WITH HALOPERIDOL DECANOATE
Authors: JANN MW WEI FC LIN HN CHING PC CHANG WH
Citation: Mw. Jann et al., HALOPERIDOL AND REDUCED HALOPERIDOL PLASMA-CONCENTRATIONS AFTER A LOADING DOSE REGIMEN WITH HALOPERIDOL DECANOATE, Progress in neuro-psychopharmacology & biological psychiatry, 20(1), 1996, pp. 73-86
MONITORING OF PLASMA CLOZAPINE LEVELS AND ITS METABOLITES IN REFRACTORY SCHIZOPHRENIC-PATIENTS
Authors: LIU HC CHANG WH WEI FC LIN SK LIN SK JANN MW
Citation: Hc. Liu et al., MONITORING OF PLASMA CLOZAPINE LEVELS AND ITS METABOLITES IN REFRACTORY SCHIZOPHRENIC-PATIENTS, Therapeutic drug monitoring, 18(2), 1996, pp. 200-207
A PRACTICAL LOADING DOSE METHOD FOR CONVERTING SCHIZOPHRENIC-PATIENTSFROM ORAL TO DEPOT HALOPERIDOL THERAPY
Authors: WEI FC JANN MW LIN HN CHING PC CHANG WH
Citation: Fc. Wei et al., A PRACTICAL LOADING DOSE METHOD FOR CONVERTING SCHIZOPHRENIC-PATIENTSFROM ORAL TO DEPOT HALOPERIDOL THERAPY, The Journal of clinical psychiatry, 57(7), 1996, pp. 298-302
LACK OF PHARMACOKINETIC INTERACTION BETWEEN BUSPIRONE AND HALOPERIDOLIN PATIENTS WITH SCHIZOPHRENIA
Authors: HUANG HF JANN MW WEI FC CHANG TP CHEN JS JUANG DJ LIN SK LAM YWF CHIEN CP CHANG WH
Citation: Hf. Huang et al., LACK OF PHARMACOKINETIC INTERACTION BETWEEN BUSPIRONE AND HALOPERIDOLIN PATIENTS WITH SCHIZOPHRENIA, Journal of clinical pharmacology, 36(10), 1996, pp. 963-969
Risultati: 1-25 | 26-41